News
Sun Pharmaceutical Industries consolidated net profit declines 36.22% in the September 2026 quarter
30-Oct-2026 | 16:29
Sales rise 11.77% to Rs 16100.01 crore
Net profit of Sun Pharmaceutical Industries declined 36.22% to Rs 1988.53 crore in the quarter ended September 2026 as against Rs 3117.95 crore during the previous quarter ended September 2025. Sales rose 11.77% to Rs 16100.01 crore in the quarter ended September 2026 as against Rs 14405.22 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 16100.01 | 14405.22 | 12 |
| OPM % | 29.47 | 31.43 | - |
| PBDT | 5186.54 | 4897.11 | 6 |
| PBT | 4428.20 | 4167.61 | 6 |
| NP | 1988.53 | 3117.95 | -36 |
Powered by Capital Market - Live News